COPENHAGEN, DENMARK, June 5, 2012 /CNW/ - NB Public Equity Komplementar
ApS announced today that it applauded the election yesterday of a new
Board of Directors of QLT Inc. (Nasdaq: QLTI) (TSX:QLT) ("QLT") at its
Annual Meeting of Shareholders held on June 4, 2012, including the
following new directors nominated by NB Public Equity K/S: Jason M.
Aryeh, Geoffrey F. Cox, John Kozarich, Jeffrey Meckler, Stephen L.
Sabba and John C. Thomas, Jr.
Mr. Florian Schönharting, Chief Investment Officer of NB Capital ApS
stated: "Today marks a new chapter in the life of QLT. The election of
the new board opens up new opportunities for QLT and we look forward to
the realization of the full potential of the company's pipeline and
Ms. Cora Madsen, managing director of NB Public Equity Komplementar
ApS, stated: "We join all other shareholders of QLT in thanking the
outgoing directors of QLT for their years of service to the company. We
are grateful of the support from significant shareholders of QLT for
our nominees and the need for change on the Board."
NB Public Equity K/S is managed by its general partner, NB Public Equity
Komplementar ApS, which in turn is 100% owned by NB Capital ApS. The
focus of NB Public Equity K/S is biopharmaceutical companies worldwide.
All three entities have main offices in and are operated from
Copenhagen, Kingdom of Denmark. The investment team has managed
institutional investment capital in biopharmaceuticals dating back to
SOURCE NB Public Equity Komplementar ApS
For further information:
For more information please visit www.nbcapital.net.